• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期风险:非心脏手术当前方法的简要综述

Perioperative Risk: Short Review of Current Approach in Non Cardiac Surgery.

作者信息

Boghean Andreea, Guțu Cristian, Firescu Dorel

机构信息

Faculty of Medicine and Pharmacy, University "Dunărea de Jos" Galați, 800008 Galati, Romania.

Emergency Military Hospital "Dr. Aristide Serfioti" Galați, 800150 Galati, Romania.

出版信息

J Cardiovasc Dev Dis. 2025 Jan 13;12(1):24. doi: 10.3390/jcdd12010024.

DOI:10.3390/jcdd12010024
PMID:39852302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11765857/
Abstract

The rate of major surgery is constantly increasing worldwide, and approximately 85% are non-cardiac surgery. More than half of patients over 45 years presenting for non-cardiac surgical interventions have cardiovascular risk factors, and the most common: chronic coronary syndrome and history of stroke. The preoperative cardiovascular risk is determined by the comorbidities, the clinical condition before the intervention, the urgency, duration or type. Cardiovascular risk scores are necessary tools to prevent perioperative cardiovascular morbidity and mortality and the most frequently used are Lee/RCRI (Revised Cardiac Risk Index), APACHE II (Acute Physiology and Chronic Health Evaluation), POSSUM (Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity), The American University of Beirut (AUB)-HAS2. To reduce the perioperative risk, there is a need for an appropriate preoperative risk assessment, as well as the choice of the type and timing of surgical intervention. Quantification of surgical risk as low, intermediate, and high is useful in identifying the group of patients who are at risk of complications such as myocardial infarction, thrombosis, arrhythmias, heart failure, stroke or even death. Currently there are not enough studies that can differentiate the risk according to gender, race, elective versus emergency procedure, the value of cardiac biomarkers.

摘要

全球范围内大手术的发生率在持续上升,其中约85%为非心脏手术。45岁以上接受非心脏外科手术干预的患者中,超过半数存在心血管危险因素,最常见的是慢性冠状动脉综合征和中风病史。术前心血管风险由合并症、干预前的临床状况、紧迫性、持续时间或类型决定。心血管风险评分是预防围手术期心血管发病率和死亡率的必要工具,最常用的有Lee/RCRI(修订心脏风险指数)、APACHE II(急性生理与慢性健康评估)、POSSUM(生理和手术严重程度评分系统用于计算死亡率和发病率)、贝鲁特美国大学(AUB)-HAS2。为降低围手术期风险,需要进行适当的术前风险评估,以及选择手术干预的类型和时机。将手术风险量化为低、中、高有助于识别有心肌梗死、血栓形成、心律失常、心力衰竭、中风甚至死亡等并发症风险的患者群体。目前尚无足够研究能够根据性别、种族、择期手术与急诊手术、心脏生物标志物的价值来区分风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/2ca33b30ed7d/jcdd-12-00024-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/02c12304a58b/jcdd-12-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/43ab690f112c/jcdd-12-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/2ca33b30ed7d/jcdd-12-00024-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/02c12304a58b/jcdd-12-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/43ab690f112c/jcdd-12-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c9c/11765857/2ca33b30ed7d/jcdd-12-00024-g003.jpg

相似文献

1
Perioperative Risk: Short Review of Current Approach in Non Cardiac Surgery.围手术期风险:非心脏手术当前方法的简要综述
J Cardiovasc Dev Dis. 2025 Jan 13;12(1):24. doi: 10.3390/jcdd12010024.
2
Comparison of preoperative NT-proBNP and simple cardiac risk scores for predicting postoperative morbidity after non-cardiac surgery with intermediate or high surgical risk.术前NT-proBNP与简单心脏风险评分在预测中高危非心脏手术后并发症方面的比较
Perioper Med (Lond). 2024 May 17;13(1):44. doi: 10.1186/s13741-024-00400-z.
3
Current multivariate risk scores in patients undergoing non-cardiac surgery.接受非心脏手术患者的当前多变量风险评分。
Monaldi Arch Chest Dis. 2017 Jul 18;87(2):848. doi: 10.4081/monaldi.2017.848.
4
AUB-HAS2 Cardiovascular Risk Index: Performance in Surgical Subpopulations and Comparison to the Revised Cardiac Risk Index.AUB-HAS2 心血管风险指数:在手术亚人群中的表现与修订后的心脏风险指数的比较。
J Am Heart Assoc. 2020 May 18;9(10):e016228. doi: 10.1161/JAHA.119.016228. Epub 2020 May 10.
5
A Risk Stratification Model for Cardiovascular Complications during the 3-Month Period after Major Elective Vascular Surgery.重大择期血管手术后 3 个月内心血管并发症的风险分层模型。
Biomed Res Int. 2018 Sep 9;2018:4381527. doi: 10.1155/2018/4381527. eCollection 2018.
6
Perioperative Risk Stratification: A Need for an Improved Assessment in Surgery and Anesthesia-A Pilot Study.围手术期风险分层:手术和麻醉中需要改进评估——一项初步研究。
Medicina (Kaunas). 2021 Oct 19;57(10):1132. doi: 10.3390/medicina57101132.
7
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
8
Prognostic value of a combination of cardiac biomarkers and risk indices for major adverse cardiovascular events following non-cardiac surgery in geriatric patients: a prospective cohort study.心脏生物标志物与风险指数联合对老年患者非心脏手术后主要不良心血管事件的预后价值:一项前瞻性队列研究
Sci Rep. 2025 Apr 17;15(1):13336. doi: 10.1038/s41598-025-95987-8.
9
Performance of the AUB-HAS2 Cardiovascular Risk Index in vascular surgery patients.血管外科患者中 AUB-HAS2 心血管风险指数的表现。
Vasc Med. 2021 Oct;26(5):535-541. doi: 10.1177/1358863X21996806. Epub 2021 Apr 5.
10
Preoperative Assessment and Management of Cardiovascular Risk in Patients Undergoing Non-Cardiac Surgery: Implementing a Systematic Stepwise Approach during the COVID-19 Pandemic Era.非心脏手术患者心血管风险的术前评估与管理:在新冠疫情时代实施系统的逐步方法
J Cardiovasc Dev Dis. 2021 Oct 3;8(10):126. doi: 10.3390/jcdd8100126.

引用本文的文献

1
Multidisciplinary Insights into Perioperative Cardiac Events in Non-Cardiac Surgery: an ECG Holter Monitoring Study.非心脏手术围手术期心脏事件的多学科见解:一项动态心电图监测研究
Maedica (Bucur). 2025 Jun;20(2):182-191. doi: 10.26574/maedica.2025.20.2.182.

本文引用的文献

1
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve -LQTS Variant Classification and Cardiac Event Risk Stratification.变异效应的多重检测和自动膜片钳技术改进了长QT综合征变异分类和心脏事件风险分层。
Circulation. 2024 Dec 3;150(23):1869-1881. doi: 10.1161/CIRCULATIONAHA.124.069828. Epub 2024 Sep 24.
2
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
3
Vitamin K Antagonist Reversal for Urgent Surgery Using 4-Factor Prothrombin Complex Concentrates: A Randomized Clinical Trial.
使用四因子凝血酶原复合物浓缩剂进行紧急手术时维生素K拮抗剂的逆转:一项随机临床试验
JAMA Netw Open. 2024 Aug 1;7(8):e2424758. doi: 10.1001/jamanetworkopen.2024.24758.
4
Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.在非心脏手术前停用或继续使用肾素-血管紧张素系统抑制剂:SPACE 试验。
Eur Heart J. 2024 Apr 1;45(13):1146-1155. doi: 10.1093/eurheartj/ehad716.
5
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
6
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
7
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.安达赛珠单抗用于治疗Xa因子抑制剂引起的严重出血的最终研究报告。
Circulation. 2023 Mar 28;147(13):1026-1038. doi: 10.1161/CIRCULATIONAHA.121.057844. Epub 2023 Feb 20.
8
A systematic review and meta-analysis of periprocedural bridging for patients with mechanical heart valves undergoing non-cardiac interventions.机械心脏瓣膜患者行非心脏介入治疗时的围术期桥接治疗:系统评价和荟萃分析
Thromb Res. 2022 Oct;218:130-137. doi: 10.1016/j.thromres.2022.08.022. Epub 2022 Aug 23.
9
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.2022年欧洲心脏病学会非心脏手术患者心血管评估与管理指南。
Eur Heart J. 2022 Oct 14;43(39):3826-3924. doi: 10.1093/eurheartj/ehac270.
10
Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery.利钠肽和肌钙蛋白预测行重大非心脏手术患者的心血管事件。
Int J Environ Res Public Health. 2022 Apr 24;19(9):5182. doi: 10.3390/ijerph19095182.